Type of Cancer
Breast Oncology
Phase
Division (Location)
Study ID
NCT#
Brief Description
DIARRHEA PREVENTION AND PROPHYLAXIS WITH CROFELEMER IN HER2 POSITIVE BREAST CANCER PATIENTS RECEIVING TRASTUZUMAB, PERTUZUMAB, AND DOCETAXEL OR PACLITAXEL WITH OR WITHOUT CARBOPLATIN
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.